VEGF Receptor Inhibitor-Induced Hypertension: Emerging Mechanisms and Clinical Implications.
VEGF Receptor Inhibitor-Induced Hypertension: Emerging Mechanisms and Clinical Implications.
复制标题
DOI:
10.1007/s11912-022-01224-0
复制
发表时间:
2022-04
影响因子:
4.7
通讯作者:
中科院分区:
文献类型:
--
作者:
While vascular endothelial growth factor receptor inhibitors (VEGFRis) have dramatically improved cancer survival, these drugs cause hypertension in a majority of patients. This side effect is often dose limiting and increases cardiovascular mortality in cancer survivors. This review summarizes recent advances in our understanding of the molecular mechanisms and clinical findings that impact management of VEGFRi-induced hypertension. Recent studies define new connections between endothelial dysfunction and VEGFRi-induced hypertension, including the balance between nitric oxide, oxidative stress, endothelin signaling, and prostaglandins and the potential role of microparticles, vascular smooth muscle cells, vascular stiffness, and microvessel rarefaction. Data implicating genetic polymorphisms that might identify patients at risk for VEGFRi-induced hypertension and the growing body of literature associating VEGFRi-induced hypertension with antitumor efficacy are reviewed. These recent advances have implications for the future of cardio-oncology clinics and the management of VEGFRi-induced hypertension.
登录
查看更多内容
影响因子:
3.3
作者:
Dabire, Hubert;Drame, Fatou;Ghaleh, Bijan
通讯作者:
Ghaleh, Bijan
DOI:
10.1161/circheartfailure.117.004408
发表时间:
2018-03
期刊:
Circulation. Heart failure
影响因子:
--
作者:
Catino AB;Hubbard RA;Chirinos JA;Townsend R;Keefe S;Haas NB;Puzanov I;Fang JC;Agarwal N;Hyman D;Smith AM;Gordon M;Plappert T;Englefield V;Narayan V;Ewer S;ElAmm C;Lenihan D;Ky B
通讯作者:
Ky B
影响因子:
158.5
作者:
Eremina, Vera;Jefferson, J. Ashley;Quaggin, Susan E.
通讯作者:
Quaggin, Susan E.
影响因子:
5.8
作者:
Hurwitz, Herbert I.;Douglas, Pamela S.;Rosen, Oliver
通讯作者:
Rosen, Oliver
影响因子:
11.5
作者:
Haller, H
通讯作者:
Haller, H